Current investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are showing encouraging results in managing weight gain and type 2 diabetes. Preclinical information suggest a distinct action https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/